1-4 of 4
Michael McGuire
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer

Takeshi Hisamatsu, Michael McGuire, Sherry Y. Wu, Rajesha Rupaimoole, Sunila Pradeep, Emine Bayraktar, Kyunghee Noh, Wei Hu, Jean M. Hansen, Yasmin Lyons, Kshipra M. Gharpure, Archana S. Nagaraja, Lingegowda S. Mangala, Takashi Mitamura, Cristian Rodriguez-Aguayo, Young Gyu Eun, Johnathon Rose, Geoffrey Bartholomeusz, Cristina Ivan, Ju-Seog Lee, Koji Matsuo, Michael Frumovitz, Kwong K. Wong, Gabriel Lopez-Berestein, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (1): 162–172.
https://doi.org/10.1158/1535-7163.MCT-17-1050
Published: 02 January 2019
View article titled, <em>PRKRA</em>/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer
Open the PDF for <em>PRKRA</em>/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer

Yan Huang, Wei Hu, Jie Huang, Fangrong Shen, Yunjie Sun, Cristina Ivan, Sunila Pradeep, Robert Dood, Monika Haemmerle, Dahai Jiang, Lingegowda S. Mangala, Kyunghee Noh, Jean M. Hansen, Heather J. Dalton, Rebecca A. Previs, Archana S. Nagaraja, Michael McGuire, Nicholas B. Jennings, Russell Broaddus, Robert L. Coleman, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (2): 464–473.
https://doi.org/10.1158/1535-7163.MCT-17-0006
Published: 01 February 2018
View article titled, Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer
Open the PDF for Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer in another window
Includes: Supplementary data
Journal Articles

Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth

Jie Huang, Wei Hu, Limin Hu, Rebecca A. Previs, Heather J. Dalton, Xiao-Yun Yang, Yunjie Sun, Michael McGuire, Rajesha Rupaimoole, Archana S. Nagaraja, Yu Kang, Tao Liu, Alpa M. Nick, Nicholas B. Jennings, Robert L. Coleman, Robert B. Jaffe, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (6): 1344–1352.
https://doi.org/10.1158/1535-7163.MCT-15-0144
Published: 02 June 2016
View article titled, Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth
Open the PDF for Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth in another window
Includes: Supplementary data
Journal Articles

Peptide targeting of the integrin αvβ6 for the treatment of non-small cell lung cancer

Shunzi Li, Mai Lin, Bethany Gray, Ying-Horng Liu, Lei Wu, Xiankai Sun, Michael McGuire, Kathlynn Brown
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): C104.
Published: 01 November 2007
View article titled, Peptide targeting of the integrin α<sub>v</sub>β<sub>6</sub> for the treatment of non-small cell lung cancer